| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) |
|
11651.50 | -74.65 | -0.64% |
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ABIOMED, Inc. (NASDAQ: ABMD)
ABMD Technical Analysis
5
| As on 31st Oct 2017 ABMD Share Price closed @ 192.92 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 135.85 & Strong Buy for SHORT-TERM with Stoploss of 163.21 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ABMD Share Price
| Open | 180.12 | Change | Price | % |
| High | 193.95 | 1 Day | 13.44 | 7.49 |
| Low | 180.12 | 1 Week | 0.00 | 0.00 |
| Close | 192.92 | 1 Month | 19.07 | 10.97 |
| Volume | 800004 | 1 Year | 82.91 | 75.37 |
| 52 Week High 193.95 | 52 Week Low 103.53 | ||||
NASDAQ USA Most Active Stocks
| YHOO | 52.58 | 0.00% |
| FNFG | 10.18 | -0.20% |
| DELL | 13.86 | 0.22% |
| RFMD | 16.59 | -2.07% |
| MU | 44.31 | 6.39% |
| RIMM | 13.03 | 0.39% |
| BBEP | 0.12 | 0.00% |
| GTAT | 0.44 | 0.00% |
| SUSQ | 14.20 | -0.77% |
| INTC | 45.49 | 2.52% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ABMD Daily Charts |
ABMD Intraday Charts |
Whats New @ Bazaartrend |
ABMD Free Analysis |
|
|
ABMD Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 205.74 |
| RESISTANCE | 200.46 |
| SUPPORT | 185.38 |
| SUPPORT | 180.10 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
ABMD Target for Month April
| 4th UP TARGET | 249.09 |
| 3rd UP TARGET | 231.08 |
| 2nd UP TARGET | 219.94 |
| 1st UP TARGET | 208.81 |
| 1st DOWN TARGET | 177.03 |
| 2nd DOWN TARGET | 165.9 |
| 3rd DOWN TARGET | 154.76 |
| 4th DOWN TARGET | 136.75 |
ABMD Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
ABMD Target for Year 2019
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
ABIOMED, Inc. ( NASDAQ USA Symbol : ABMD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ABMD Other Details
| Segment | EQ | |
| Market Capital | 527299872.00 | |
| Sector | Healthcare | |
| Industry | Medical Appliances & Equipment | |
| Offical website | http://www.abiomed.com | |
ABMD Address
 |
22 Cherry Hill Drive Danvers, MA 01923 United States Phone: 978-646-1400 Fax: 978-777-8411 |
|
ABMD Latest News
ABMD Business Profile
ABIOMED, Inc., incorporated on June 4, 1987, is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart.
The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. In September 2012, the Company announced that its Impella CP product received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for partial circulatory support for up to six hours.
In November 2012, the Company announced that the Impella RP received Investigational Device Exemption, or IDE, approval from the FDA for use in RECOVER RIGHT, a pivotal clinical study in the U.S. In December 2012, as part of the FDA's 515 Program Initiative, an FDA panel voted to recommend continuation of Class III status for temporary ventricular support devices within the non-roller type cardiopulmonary bypass blood pumps category, which includes the Company's Impella products.
The Company Headquarters is at 22 Cherry Hill Drive, Danvers, Massachusetts 01923.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
